What is the prevalence of Pars Planitis?

Pars planitis is a rare form of intermediate uveitis characterized by inflammation of the pars plana region of the eye, with an estimated prevalence of approximately 1.3 to 2.2 per 100,000 individuals. Because Pars planitis is frequently asymptomatic in its early stages or misdiagnosed as other ocular conditions, these figures are considered conservative estimates that likely underrepresent the true global burden.

Who is most affected by Pars planitis?

Pars planitis typically presents in children and young adults, with most patients receiving a diagnosis between the ages of 5 and 30. While population-based studies suggest that Pars planitis affects males and females with relatively equal frequency, some clinical cohorts report a slight male predominance. The condition is not restricted to any specific ethnic group or geographic region, though it is recognized as a leading cause of pediatric uveitis in Western countries.

Why is accurate data for Pars planitis difficult to obtain?

Calculating the exact prevalence of Pars planitis is challenging due to several factors:

• Asymptomatic onset: Many patients do not experience pain, leading to delayed diagnosis until vision loss or "floaters" become severe.


• Diagnostic variability: Pars planitis is a diagnosis of exclusion, and inconsistent clinical criteria across different ophthalmological practices can lead to misclassification.


• Underreporting: As a rare condition, many cases are managed in private optometry or general ophthalmology clinics rather than specialized uveitis centers, leading to gaps in national health registries.

How does the DiseaseMaps.org community compare?

Currently, 21 people with Pars planitis have joined the DiseaseMaps.org community. While this represents a small subset of the total global population, these members provide vital real-world data regarding the diagnostic journey and the long-term management of Pars planitis. Connecting with others through platforms like DiseaseMaps.org can help mitigate the isolation often felt by those living with this rare ocular inflammatory disease.

Next steps

• Consult with a fellowship-trained uveitis specialist to ensure an accurate diagnosis and a personalized treatment plan.


• Monitor vision changes closely, as early intervention in Pars planitis is critical to preventing complications like cystoid macular edema.


• Join the DiseaseMaps.org community to share experiences and track symptom progression with other patients.

Medical Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• Orphanet: Rare Diseases Database (ORPHA:3335).


• NIH Genetic and Rare Diseases Information Center (GARD).


• American Academy of Ophthalmology: Uveitis and Ocular Immunology clinical guidelines.


• PubMed: "Epidemiology of Intermediate Uveitis" (National Library of Medicine).